Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
BorgWarner Inc. filed an amendment to a previous 8-K to disclose the committee assignments for Rajesh Kalathur, who was appointed to the Board of Directors on July 30, 2026. The Board has now appointed Mr. Kalathur to serve as a member of the Audit Committee, effective November 11, 2026.
For the nine months ended September 30, 2026, FB Bancorp reported net income of $515 thousand, a significant decrease from $2.66 million in the prior year period, primarily due to a $1.14 million loss from discontinued operations and increased non-interest expenses. Total assets decreased to $1.21 billion from $1.26 billion at year-end 2025, while stockholders' equity was impacted by $32.3 million in common stock repurchases.
Yorkville International Capital Corp. is a special purpose acquisition company (SPAC) that completed its IPO on June 17, 2026, raising $230 million held in a trust account. As of September 30, 2026, the company is in its search phase for an initial business combination and reported 23,000,000 Class A and 15,333,333 Class B ordinary shares outstanding.
TRG Latin America Acquisitions Corp. is a special purpose acquisition company (SPAC) that completed its IPO on February 27, 2026, raising proceeds for a trust account totaling $210,677,645 as of September 30, 2026. The company is currently in its combination period with a deadline of February 27, 2028, to consummate an initial business combination.
John Christopher Shelton was elected to the Board of Directors of IPALCO Enterprises, Inc. to fill a vacancy. Mr. Shelton, who currently serves as Senior Vice President and Chief Product Officer of The AES Corporation, was nominated by AES U.S. Investments, Inc. pursuant to a shareholders' agreement. He will not receive separate compensation for his service on the IPALCO Board.
American Tower $1.5B Debt Financing with U.S. Bank Trust Company, National Association
American Tower Corporation completed a registered public offering of $1.5 billion in aggregate principal amount of senior unsecured notes across three tranches maturing in 2031, 2033, and 2036. The net proceeds of approximately $1,474.9 million are intended to repay existing indebtedness under the company's $6.0 billion multicurrency revolving credit facility and for general corporate purposes.
Pony Group Inc. reported a net loss of $147,554 for the nine months ended September 30, 2026, compared to a loss of $115,100 in the prior year period. Total revenue decreased slightly to $97,880 from $104,137, while the company continues to operate with a significant stockholders' deficit of $1,100,109.
Owlet, Inc. reported 29,889,307 shares of Class A Common Stock outstanding as of November 9, 2026. The filing highlights significant risks including a history of losses, reliance on single manufacturers for key products like Dream Sock and Owlet Cam, and a recent camera cable guard safety update and stop sale initiated in November 2026.
Bluejay Diagnostics provided a corporate update for Q3 2026, highlighting the completion of enrollment for its SYMON-II clinical study and the establishment of an alternative manufacturing site ahead of schedule. The company reported a cash balance of $7.38 million and targets an FDA 510(k) submission for its Symphony IL-6 platform in the first half of 2027.
Curis reported financial results for the third quarter of 2026 and provided an operational update on its TakeAim CLL and TakeAim Lymphoma clinical trials. The company highlighted progress in combining emavusertib with BTK inhibitors for the treatment of CLL and PCNSL, with initial data from the TakeAim CLL study expected in December 2026.
Term
Q3 2026
“The excitement among clinicians and patients reflects the clear unmet need in both CLL and PCNSL, where emavusertib has the potential to change the treatment landscape when combined with approved BTK inhibitors.”
TherapeuticsMD reported third quarter 2026 financial results, highlighting license revenue of $1.3 million, a 60.6% increase year-over-year. The company achieved a $0.5 million net income from continuing operations and ended the period with $10.4 million in cash. Management noted the achievement of a sales-based milestone for IMVEXXY and continues to evaluate strategic alternatives including potential mergers or asset sales.
Skyworks Solutions announced committee assignments for newly appointed directors Richard L. Clemmer and Christopher R. Koopmans. Mr. Clemmer will join the Compensation and Talent Committee, while Mr. Koopmans will join the Nominating and Corporate Governance Committee, effective November 11, 2026.
Espey Mfg. & Electronics Corp. reported net sales of $10.6 million for the quarter ended September 30, 2026, a 16.7% increase over the prior year. Despite higher sales, net income remained relatively flat at $2.19 million due to increased cost of sales and lower interest income.
BullFrog AI Holdings, Inc. reported a net loss of $4,976,572 for the nine months ended September 30, 2026, compared to a loss of $5,017,894 in the prior year period. While collaboration revenue increased to $278,963, the company continues to incur significant operating expenses primarily driven by general and administrative costs and research and development.
OptimumBank Holdings, Inc. reported a significant increase in net income to $18.5 million for the nine months ended September 30, 2026, compared to $11.8 million in the prior year. Total assets grew to $1.58 billion, driven by a substantial increase in the loan portfolio and the issuance of $34.4 million in subordinated debt.
Skye Bioscience reported a significant decrease in cash and short-term investments from $25.7 million at year-end 2025 to $4.8 million as of September 30, 2026. The company experienced a net loss of $23.2 million for the first nine months of 2026, driven primarily by $13.2 million in research and development expenses. A 1-for-8 reverse stock split was effected on August 24, 2026.
National Presto Industries reported a significant increase in net earnings for the nine months ended October 4, 2026, reaching $42.5 million compared to $18.1 million in the prior year period. This growth was driven by a 20.6% increase in net sales to $409.6 million and improved gross profit margins, alongside a $1.7 million gain from the sale of property, plant, and equipment.
LCI Industries entered into a transaction bonus agreement with its CFO, Lillian D. Etzkorn, in recognition of her efforts regarding the pending merger with Patrick Industries. Ms. Etzkorn is eligible for a cash bonus of $486,675, with 40% vesting upon the merger closing (or termination) and 60% vesting six months after the closing date, subject to continued employment.
Creative Medical Technology Holdings Nasdaq/NYSE Compliance Notice
Creative Medical Technology Holdings received a deficiency notice from Nasdaq on November 10, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has until May 10, 2027, to regain compliance by having its stock close at or above $1.00 for at least ten consecutive business days. The notice has no immediate impact on the listing of the company's common stock (CELZ).
Orrstown Financial Services executed a strategic repositioning of its available-for-sale (AFS) securities portfolio, selling $185.6 million in securities with a 3.13% yield to reinvest in higher-yielding securities at approximately 5.20%. The transaction will result in a $13.8 million pre-tax loss in Q4 2026 but is expected to be accretive to net interest margin and earnings in future periods.
NextNRG, Inc. received a final determination from the Nasdaq Hearings Panel to delist its common stock after failing to meet the $1.00 minimum bid price and $35 million market value requirements. Trading on Nasdaq was suspended effective November 12, 2026, and the company's shares began quoting on the OTC Markets under the symbol 'NXXT'.
AB Private Lending Fund reported a net increase in net assets resulting from operations of $8.86 million for the nine months ended September 30, 2026, compared to $9.22 million in the prior year period. Total investment income grew to $25.86 million, though net investment income per share decreased from $1.86 to $1.69 due to a higher weighted average share count.
First National Corp reported net income of $1.25 per share for both the third quarter and the first nine months of 2026. The company maintained stable dividend payouts and saw a slight increase in total assets compared to the prior year-end, supported by growth in interest and fees on loans.
Enveric Biosciences reported financial results for the third quarter of 2026 and provided a corporate update on its lead candidate EB-003. The company is completing final IND-enabling activities for EB-003, a non-hallucinogenic neuroplastogenic candidate, with plans for an IND submission and Phase 1 clinical trial.
Term
Q3 2026
“Our focus during the third quarter was advancing final IND-enabling activities for EB-003 as we prepare for the planned IND submission and first-in-human Phase 1 clinical trial of our lead non-hallucinogenic, neuroplastogenic candidate.”
Joseph Tucker, Ph.D., Chief Executive Officer of Enveric
“The growing body of preclinical evidence reinforces our confidence in this opportunity as we complete the final IND-enabling activities and prepare to advance EB-003 toward first-in-human clinical development.”
Joseph Tucker, Ph.D., Chief Executive Officer of Enveric
Aptera Motors reported a GAAP net loss of $14.0 million for the third quarter of 2026, with research and development spending more than doubling year-over-year. The company ended the quarter with $9.2 million in cash and highlighted a new strategic partnership with Shanghai Launch Automotive Technology to support manufacturing and contract engineering.
Term
Q3 2026
“In the third quarter we started the process of procuring parts for our first production vehicles. We also entered into a strategic partnership with Launch to support manufacturing and contract engineering, which we believe has helped lower our estimated capital needs to reach start of production and, most importantly, the capital we estimate is required to reach a production rate at which we believe we could fund ongoing operations from vehicle sales.”
SenesTech, Inc. reported a net loss of $5.85 million for the nine months ended September 30, 2026, compared to $4.58 million in the prior year period, despite a 31% increase in total revenues to $2.36 million. The company's cash position decreased to $3.95 million, and management indicated that current resources are only sufficient to fund operations for approximately nine months from the filing date.
For the nine months ended September 30, 2026, the WisdomTree Bitcoin Fund reported a net decrease in net assets resulting from operations of $1,601,685, primarily driven by a net change in unrealized depreciation on bitcoin. Despite the operational loss, net assets grew to $171.9 million from $139.7 million at the start of the year, bolstered by $33.9 million in net capital share transactions.
Amesite Inc. reported a net loss of $774,395 for the quarter ended September 30, 2026, compared to a loss of $642,266 in the prior year period, driven by increased technology and content development costs. The company's management expressed substantial doubt about its ability to continue as a going concern, noting that current cash reserves may not sustain operations for the next twelve months.
Athena Technology Acquisition Corp. II Other 8-K Filing
Athena Technology Acquisition Corp. II deposited $271.48 into its trust account to extend the deadline for completing its initial business combination by one month. This Monthly Extension moves the deadline from November 14, 2026, to December 14, 2026, and represents the sixth of nine permitted monthly extensions.
ESS Tech, Inc. has ceased all operations and filed a voluntary petition for relief under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware. A court-appointed trustee will assume control of the company's assets for liquidation, and all employees and officers, including the CEO and CFO, have been terminated. The company stated it is unlikely that common stockholders will receive any distribution and that it will no longer file periodic reports with the SEC.